Suppr超能文献

[九省市新型冠状病毒肺炎临床治疗情况的全国性调查]

[Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].

作者信息

Liu Shaohua, Ding Xianfei, Cao Junzi, Zhang Shuguang, Sun Tongwen

机构信息

General ICU, the First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou Key Laboratory of Sepsis, Zhengzhou 450052, Henan, China.

Critical Care Medicine Professional Committee of Chinese Research Hospital Association, Zhengzhou 450052, Henan, China. Corresponding author: Sun Tongwen, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):397-400. doi: 10.3760/cma.j.cn121430-20200313-00338.

Abstract

OBJECTIVE

To investigate the clinical treatment and assess the knowledge and use of the coronavirus disease 2019 (COVID-19) treatment plan issued by the nation.

METHODS

A nationwide questionnaire survey on line was administered to medical staffs involved in COVID-19 treatment on February 28th, 2020. The questionnaire included drug treatment, respiratory support therapy, sedation and analgesia, continuous renal replacement therapy (CRRT) and extracorporeal membrane oxygenation (ECMO), etc.

RESULTS

There were 1 103 respondents, of whom 699 (504 doctors and 195 nurses) participated in the treatment of COVID-19. Finally, 432 doctors and 170 nurses from 9 provinces submitted valid questionnaires. The results of the questionnaire surveys of doctors and nurses were basically the same. Considering that doctors dominated in the diagnosis and treatment of COVID-19, the results of the questionnaires of doctors were mainly analyzed. The doctors participating in the survey were mainly from Hubei (29.2%), followed by Henan (24.5%), Guizhou (22.7%), and Guangxi (14.6%), etc. 55.4% of the doctors came from tertiary three hospitals, and most of them have senior titles (56.4%). 232 doctors (53.7%) participated in the treatment of mild COVID-19, and 200 doctors (46.3%) participated in the treatment of severe and critically ill patients. More than 95% of the doctors expressed that they would carry out antiviral treatment for patients with COVID-19 regardless of disease severity. The main antiviral drugs included α-interferon (69.5%), lopinavir/ritonavir (65.0%), abidol (60.0%), and ribavirin (55.7%). The choice of antiviral drugs was highly consistent with the national treatment programs of COVID-19. At the same time, 95.5% of doctors would routinely prescribe antibiotics to severe and critically ill patients. 94.0% of doctors agreed to prescribe low-dose glucocorticoid therapy to severe and critically ill patients. About 2/3 of doctors would perform lung recruitment or prone position treatment for critical patients with invasive ventilation. 79.0% of doctors preferred to use deep sedation for patients with invasive ventilation. About 1/3 of doctors believed that CRRT should be initiated early, and nearly 1/3 of doctors suggested that ECMO should be used more aggressively in critically ill patients.

CONCLUSIONS

Medical staffs are familiar with the national treatment plan of COVID-19 and willing to follow it. However, as a new disease, we have limited knowledge about COVID-19 and there are still many controversies. Further practical training is needed to make clinicians more aware of the disease, and more evidence-based evidence is needed to guide clinical treatment.

摘要

目的

调查新冠病毒病(COVID-19)的临床治疗情况,并评估全国发布的COVID-19治疗方案的知晓及使用情况。

方法

2020年2月28日对参与COVID-19治疗的医务人员进行了全国范围内的在线问卷调查。问卷内容包括药物治疗、呼吸支持治疗、镇静镇痛、持续肾脏替代治疗(CRRT)和体外膜肺氧合(ECMO)等。

结果

共有1103名受访者,其中699人(504名医生和195名护士)参与了COVID-19的治疗。最终,来自9个省份的432名医生和170名护士提交了有效问卷。医生和护士的问卷调查结果基本相同。鉴于医生在COVID-19的诊断和治疗中占主导地位,主要分析医生的问卷结果。参与调查的医生主要来自湖北(29.2%),其次是河南(24.5%)、贵州(22.7%)和广西(14.6%)等。55.4%的医生来自三级甲等医院,且大多数拥有高级职称(56.4%)。232名医生(53.7%)参与了轻症COVID-19的治疗,200名医生(46.3%)参与了重症和危重症患者的治疗。超过95%的医生表示,无论疾病严重程度如何,都会对COVID-19患者进行抗病毒治疗。主要的抗病毒药物包括α-干扰素(69.5%)、洛匹那韦/利托那韦(65.0%)、阿比多尔(60.0%)和利巴韦林(55.7%)。抗病毒药物的选择与国家COVID-19治疗方案高度一致。同时,95.5%的医生会对重症和危重症患者常规使用抗生素。94.0%的医生同意对重症和危重症患者采用低剂量糖皮质激素治疗。约2/3的医生会对有创通气的危重症患者进行肺复张或俯卧位治疗。79.0%的医生倾向于对有创通气患者采用深度镇静。约1/3的医生认为应尽早开始CRRT,近1/3的医生建议在危重症患者中更积极地使用ECMO。

结论

医务人员熟悉国家COVID-19治疗方案并愿意遵循。然而,作为一种新疾病,我们对COVID-19的了解有限,仍存在许多争议。需要进一步的实践培训,以使临床医生更了解该疾病,并且需要更多循证依据来指导临床治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验